Summarize the gynecologic findings and abnormalities for a reproductive‑age woman with secondary infertility, polycystic ovarian syndrome, endometriosis, irregular menstrual cycles (last menstrual period approximately seven months ago), a confirmed seven‑week intra‑uterine pregnancy, genital warts, a prior abnormal Pap smear, LH level of 10.8 IU/L, no hysterectomy or intra‑uterine device, recent progestin (medroxyprogesterone) challenge and combined oral contraceptive (ethinyl estradiol + drospirenone) use, and current medications metformin and tuberculosis therapy.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Gynecological Summary: Complex Reproductive History with Multiple Diagnoses

This patient presents with documented secondary infertility, polycystic ovarian syndrome (PCOS), endometriosis, and a history of genital warts with prior abnormal Pap smear, currently with a confirmed 7-week intrauterine pregnancy.

Key Gynecological Findings

Reproductive Diagnoses

  • Secondary infertility (documented problem list)
  • PCOS (confirmed diagnosis on problem list)
  • Endometriosis (confirmed diagnosis on problem list)
  • Severe dysmenorrhea (documented)

Menstrual History

  • Highly irregular cycles: LMP documented as 7 months prior to one visit, with another LMP date showing significant variability
  • Anovulatory pattern: Consistent with PCOS pathophysiology 1
  • Required progestin challenge (Provera) to induce withdrawal bleeding—a diagnostic and therapeutic intervention for chronic anovulation 1

Infectious/Neoplastic History

  • Genital warts (documented in 1999 and on Flagyl treatment)
  • Abnormal Pap smear 3 years prior (specific date noted)
  • Normal Pap smear on most recent well-woman exam
  • Cervical dysplasia noted in clinical context

Hormonal Assessment

  • LH 10.8 IU/L: Within expected range, though the LH:FSH ratio context is not provided
  • No documented hormonal conditions per insurance records at one timepoint
  • PCOS typically presents with elevated LH:FSH ratio, but normal LH does not exclude the diagnosis 1

Current Pregnancy Status

  • 7-week confirmed intrauterine pregnancy with OB/GYN referral
  • This pregnancy occurred despite documented infertility and irregular cycles
  • Critical consideration: Patient was on metformin 500mg (titrated to TID dosing) and combined oral contraceptives (ethinyl estradiol + drospirenone/Yasmin) prior to conception

Medication History Analysis

Contraceptive Use

  • Ortho Novum (norethindrone/ethinyl estradiol): Last filled on documented date
  • Ortho Evra patch (norelgestromin/ethinyl estradiol): Documented use
  • Yasmin (drospirenone 3mg/ethinyl estradiol): Prescribed to start on first day of bleeding after Provera course 2

Critical point: Combined hormonal contraceptives are first-line for menstrual regulation in PCOS when pregnancy is not desired 1. The pregnancy occurred despite contraceptive prescriptions, suggesting either non-compliance or conception during a medication transition period.

Metabolic Management

  • Metformin 500mg: Titrated from once daily to three times daily (standard PCOS dosing)
  • Metformin is recommended for PCOS patients with impaired glucose tolerance or type 2 diabetes who fail lifestyle modification 1
  • Metformin should be discontinued with positive pregnancy test when used for PCOS (not diabetes), as routine use during pregnancy shows no benefit for preventing preeclampsia, preterm delivery, or gestational diabetes 1

Ovulation Induction History

  • Provera challenge administered—standard approach to induce withdrawal bleeding in amenorrheic PCOS patients
  • No documentation of clomiphene citrate or letrozole use, which are first-line treatments for anovulatory infertility in PCOS 1

Imaging and Procedures

  • Transvaginal ultrasound performed (documented procedure)
  • Normal pelvic exam documented on multiple occasions
  • No hysterectomy, no IUD documented
  • Ultrasound findings for PCOS diagnosis (follicle count >25 or ovarian volume >10 mL) not explicitly stated in records 3

Endometrial Considerations

Women with PCOS have significant endometrial abnormalities that may contribute to infertility and pregnancy complications 4, 5:

  • Altered steroid hormone receptor expression (estrogen, progesterone, androgen receptors)
  • Impaired endometrial receptivity markers (HOXA10, αvβ3 integrin)
  • Chronic anovulation leads to unopposed estrogen exposure, increasing endometrial hyperplasia and cancer risk
  • Endometriosis co-diagnosis further complicates endometrial function through inflammation and adhesions 6

The combination of PCOS and endometriosis creates a particularly challenging fertility scenario, as both conditions independently impair conception through different mechanisms 3.

Clinical Trajectory

  1. Initial presentation: Secondary infertility with irregular cycles (7-month amenorrhea)
  2. Diagnostic workup: Confirmed PCOS, endometriosis, normal LH
  3. Treatment attempts: Progestin challenge, combined oral contraceptives, metformin
  4. Outcome: Spontaneous conception resulting in 7-week viable pregnancy
  5. Appropriate referral: OB/GYN for high-risk pregnancy management

Critical Management Points for Current Pregnancy

Immediate actions required:

  • Discontinue metformin if being used solely for PCOS (not diabetes) 1
  • Verify discontinuation of all hormonal contraceptives
  • Screen for gestational diabetes given PCOS diagnosis and metformin use
  • Monitor for pregnancy complications: preeclampsia, preterm delivery (increased risk in PCOS) 1
  • Assess endometriosis impact on pregnancy (increased risk of ectopic pregnancy, though intrauterine location confirmed)

Cervical Surveillance Needs

Given history of:

  • Genital warts (HPV exposure)
  • Prior abnormal Pap smear
  • Cervical dysplasia documentation

Continued cervical cancer screening per guidelines is essential, though specific interventions during pregnancy are limited. Colposcopy can be performed safely in pregnancy if indicated.

Long-term Considerations

Post-pregnancy management will require:

  • Resumption of metabolic management for PCOS (lifestyle modification first-line, metformin if impaired glucose tolerance persists) 1
  • Contraceptive counseling if future pregnancy not desired
  • Continued endometrial protection (either through hormonal contraceptives or cyclic progestins) to prevent endometrial hyperplasia from chronic anovulation 1
  • Cardiovascular risk assessment (PCOS patients are at increased risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease) 1

This patient's successful conception despite documented infertility, PCOS, and endometriosis demonstrates the unpredictable nature of fertility in these conditions, though it does not negate the underlying diagnoses or eliminate future fertility challenges.

References

3
Guideline

acr appropriateness criteria® female infertility.

Journal of the American College of Radiology, 2020

4
Research

Polycystic ovary syndrome: Endometrial markers.

Best practice & research. Clinical obstetrics & gynaecology, 2016

Related Questions

Are the following hormone and insulin results—follicle‑stimulating hormone 3.2 IU/L, luteinizing hormone 4.6 IU/L, prolactin (value not provided), estradiol 272 pmol/L, progesterone 1.5 nmol/L, testosterone 2.4 nmol/L, insulin 33 U/mL—compatible with a diagnosis of polycystic ovary syndrome (PCOS)?
What is the recommended assessment and management plan for polycystic ovarian syndrome (PCOS) with metabolic involvement?
What is the most likely cause of early miscarriage in a patient with polycystic ovary syndrome and a male partner with low sperm motility, given a normal hysterosalpingogram?
Which of the following statements about central diabetes insipidus is incorrect? A) It is characterized by a deficiency of antidiuretic hormone, accompanied by polyuria and polydipsia. B) Hypernatremia may develop if an adequate amount of water is not consumed. C) It is classified into primary and secondary forms. D) The diagnosis is primarily clinical. E) It usually does not require specific treatment.
In a newborn, how is the bilirubin‑albumin ratio calculated and what ratio thresholds guide the need for phototherapy, IVIG, albumin infusion, or exchange transfusion?
How should a suspected wire perforation be managed during an invasive procedure?
What are the adverse effects of solifenacin (Vesicare) and how should they be monitored and managed, especially in older adults with pre‑existing constipation or cognitive impairment?
What is the appropriate evaluation and management for a 73-year-old patient with brief episodes of lightheadedness and dizziness lasting about one minute?
What discontinuation symptoms might a person with bipolar disorder experience after missing two days of quetiapine (Seroquel) 50 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.